Headed to Asembia? Let’s connect.
EVERSANA has rapidly grown our next-generation commercialization services and created new solutions to solve any drug pricing, promotion, access, reimbursement, adherence or product delivery challenge.
Meet our team at Asembia at Booth # 1309.
Our experts across Patient Services, Market Access and Distribution will be on-site.
What’s New?
Our new, fully operational direct-to-patient model, EVERSANA DIRECT Commercialization, has transformed the way patients access and adhere to therapies, and the only integrated functional model in the industry. It was built to create a seamless, cost-effective care journey.
- Accelerates time to therapy by 85%
- Reduces acquisition costs by 30-50%
- Improves adherence by up to 70%
Stop by our booth (#1309) to learn more.
What’s More to Explore?
At EVERSANA, our team of experts leverage technology and automation to reduce access and affordability barriers, simplify onboarding and get patients on therapy faster, ultimately reducing frustrations and driving therapy adoption. Our Patient Services team is surrounded by best-in-class Field Deployment, Agency, Channel Management and more to ensure a positive brand experience. Explore more:
- Patient Services Programs
- Field Deployment – Commercial and Medical Teams
- Global Channel Distribution and 3PL
- Creative and Digital Agency with specialization in Market Access
- Trade, Access and Payer Strategies
ESTABLISHED MODELS FOR ONCOLOGY, RARE & HIGH-SCIENCE BRANDS
We understand the needs and sophistication of complex therapies. Our award-winning commercialization models were developed to be agile, flexible and cost-effective, and to lower the risk of uncertainty. They are digital first and powered by data, analytics and AI.
- Agility to pivot strategies without a “change order” mentality
- Speed to market
- Risk management
- Owners maintain full value of their asset